Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
64.88 USD | -0.68% | -0.26% | -19.45% |
05-02 | UBS Adjusts Price Target on Gilead Sciences to $70 From $75, Maintains Neutral Rating | MT |
05-01 | Deutsche Bank Adjusts Price Target on Gilead Sciences to $73 From $75 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.45% | 81.46B | |
+26.21% | 681B | |
+21.59% | 556B | |
-4.96% | 361B | |
+17.29% | 325B | |
+5.29% | 285B | |
+13.94% | 235B | |
+4.12% | 199B | |
-11.33% | 189B | |
-3.89% | 157B |
- Stock Market
- Equities
- GILD Stock
- News Gilead Sciences, Inc.
- Gilead Sciences Shares Spike Premarket, Trodelvy 'Significantly' Improves Overall Survival